Health and Healthcare
Generex Biotech Holders File To Unload (GNBT)
Published:
Last Updated:
Generex Biotechnology Company (NASDAQ: GNBT), a drugdelivery system and technology developer, has filed an offering by sellingstockholders of up to 74,475,861 shares of common stock. The proposed maximum aggregateoffering price is $78,199,653, but this number is for filing purposes.
The offering consists of up to 22,527,275 shares of commonstock issuable upon conversions of a $20,650,000 principal amount of 8% SecuredConvertible Notes due September 2009, and up to 51,198,347 shares of commonstock issuable upon the exercise of warrants.
The company itself will not receive any proceeds fromthe offering.
Generex is up almost 1% to $1.07 in early morning trading.The market cap sits at $119.3 million and the 52-week range is $0.81 to $2.14.
You can join our open email distribution list to hear about previews for other mergers, spin-offs, break-ups, IPO’s, special financings, and other special situations.
Rachel Lopez
May 1, 2008
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
